Sign in / Join Now
ETFs & Funds
H. T. Love
: CTM vaccine
cell response positive @ 4 mth & stays strng @ 7 mth
2 rvu. Strng emerging trnd ftr lst of 4 schd trtmnts Prmkt +5%.
Add a reply...
Latest StockTalks »
people get VICL breaking news and analysis by email alert.
Get email alerts on VICL »
Get latest price
From other sites
Vical Announces Initiation Of A Phase 2 Trial Of Its HSV-2 Therapeutic DNA Vaccine For Genital Herpes
at TheStreet (Sep 26, 2016)
Vical Slumps, Cytomegalovirus Vaccine Fails in Phase II Study
at Zacks.com (Sep 20, 2016)
Vical And Astellas Announce Topline Results From A Phase 2 Study Of Investigational Cytomegalovirus (CMV) Vaccine (ASP0113) In Kidney Transplant Patients
at TheStreet (Sep 19, 2016)
Vical To Present At The 18th Annual Rodman & Renshaw Global Investment Conference
at TheStreet (Sep 2, 2016)
Vical Reports Second Quarter 2016 Financial Results
at TheStreet (Aug 9, 2016)